Afterload reduction in the critically ill: nicergoline versus sodium nitroprusside

Area of Science:

• Critical Care Medicine
• Pharmacology
• Hemodynamics

Background:

• Critically ill patients often experience low cardiac output during acute illness, necessitating effective vasodilating therapies.
• Existing vasodilators like sodium nitroprusside (NP) may have limitations in improving hemodynamic parameters in such patients.

Purpose of the Study:

• To compare the efficacy of nicergoline (NIC), a selective alpha 1-blocker, with sodium nitroprusside (NP) in improving cardiac output in critically ill patients.

Main Methods:

• A comparative study involving seven critically ill patients in a low flow state (septic or postoperative).
• Administration of sodium nitroprusside (20-100 micrograms/min) and nicergoline (0.5 to 2.5 mg/min).
• Monitoring of arterial pressure, pulmonary artery balloon-occluded pressure, heart rate, and stroke volume.

Main Results:

• Sodium nitroprusside decreased arterial pressure and pulmonary artery balloon-occluded pressure but did not increase stroke volume or cardiac output.
• Nicergoline significantly increased stroke volume and cardiac output while causing a less significant decrease in arterial pressure.
• Both agents adversely affected arterial blood oxygenation.

Conclusions:

• Nicergoline demonstrates potential as a valuable vasodilating agent in critically ill patients with low cardiac output due to its ability to increase stroke volume and cardiac output.
• NIC's negative chronotropic action may prevent baroreceptor-mediated increases in heart rate, contributing to its distinct hemodynamic effects compared to NP.
• Further investigation into NIC's role in managing acute hemodynamic instability is warranted.